Contract HHSD2002016M89090P
Enzo Life Sciences, Inc · Department Of Health And Human Services · March 30, 2016
Enzo Life Sciences, Inc was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on March 30, 2016 for $9,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Farmingdale, NY. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- HHSD2002016M89090P
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Farmingdale, NY
- First action
- March 30, 2016
Description
IGF::OT::IGF MICROSYSTINS CDC LAB SUPPLY
Modification timeline
-
March 30, 2016Base award$9.2K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $313.4K |
| Roche Diagnostics Corporation | Department Of Health And Human Services | April 1, 2026 | $75.2K |
| Sysmex America, Inc | Department Of Health And Human Services | March 31, 2026 | $49.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | March 31, 2026 | $5.7K |
| Biomerieux Inc | Department Of Health And Human Services | March 31, 2026 | $0 |
| Beckman Coulter, Inc. | Department Of Health And Human Services | March 30, 2026 | $80.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Abbott Rapid Dx North America Llc | 651 | $3.51B |
| 2 | Ihealth Labs Inc. | 4 | $2.13B |
| 3 | Roche Diagnostics Corporation | 5,604 | $959.60M |
| 4 | Siemens Healthcare Diagnostics Inc. | 818 | $641.45M |
| 5 | Cepheid | 3,693 | $639.45M |
| 6 | Remel Inc. | 4,525 | $464.47M |
| 7 | Access Bio, Inc. | 5 | $340.72M |
| 8 | Ortho-Clinical Diagnostics, Inc | 1,964 | $227.77M |
| 9 | Quidel Corp | 96 | $194.78M |
| 10 | Ortho-Clinical Diagnostics Inc | 2,494 | $183.46M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSD2002016M89090P?
Contract HHSD2002016M89090P is a federal contract awarded to Enzo Life Sciences, Inc by Department Of Health And Human Services on March 30, 2016 for $9,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 0 times since the base award.
Who won contract HHSD2002016M89090P?
Enzo Life Sciences, Inc won contract HHSD2002016M89090P from Department Of Health And Human Services.
How much is contract HHSD2002016M89090P worth?
Contract HHSD2002016M89090P has obligated $9,000 to date.